FEATURES OF ARTERIAL HYPERTENSION IN YOUNG PEOPLE
Abstrak
The Arterial Hypertension is part of the group of cardiovascular diseases that
represent the highest proportion of death causes by diseases thus highlighting the need
to evaluate the risk factors that contribute to this clinical situation and its high
prevalence[1]. According to official data from the World Health Organization,
complications of AH cause 9.4 million deaths worldwide annually [2]. It accounts for
at least 45% of deaths caused by heart disease and 51% of deaths caused by stroke [3].
AH is also the most common risk factor for peripheral arterial disease, chronic kidney
disease and cognitive impairment [4]. Despite the fact that the epidemiological
relationship between high blood pressure and cardiovascular disease and mortality is
well known, the number of patients with AH is steadily increasing. Some studies
estimate that there is a high probability of global spread of arterial hypertension, which
may reach 29% of the population by 2025 [5].
##submission.citations##
References:
Anthony J. Viera, Sha Zhu, Alan L. Hinderliter , DaichiShimbo , Sharina D. Person,
David R. Jacobs. Diurnal blood pressure pattern and development of
prehypertension or hypertension in young adults: the CARDIA study // Journal of
the American Society of Hypertension.- 2011.- V.5.- Issue 1.- 48–55
Barmagambetova A.T. Prevalence of arterial hypertension in Kazakhstan and
abroad// Bulletin of KazNMU.- 2013.- No. 1.- ISSN 2524 - 0692 ( online ) .– RU
Boytsov S. A., Balanova Yu. A., Shalnova S. A., Deev A. D., Artamonova G. V.,
et al. Arterial hypertension among individuals aged 25-64 years: prevalence,
awareness, treatment and control. Based on the ESSE study // Cardiovascular
therapy and prevention . [EI ]. – 2014.– 13, No. 4.– P. 4-14.– Rus.– ISSN 1728-
– RU.
Global action plan for the prevention and control of noncommunicable diseases
–2020// WHO. – 2013. – 107 p. 15 Michael H Olsen , Sonia Y Angell , Samira
Asma , et al.A call to action and life course strategy to address the global burden of
raised blood pressure on current and future generations : the Lancet Commission on
hypertension // The Lancet . - 2016.-Vol. 388:2665-2712
Global, regional, and national comparative risk assessment of 79 behavioral ,
environmental and occupational, and metabolic risks or clusters of risks, 1990-
: a systematic analysis for the Global Burden of Disease Study 2015. URL:
https://pubmed.ncbi.nlm.nih.gov/27733284/
Kamyshansky O.A. Prevalence of risk factors for cardiovascular diseases and
structural and functional characteristics of the cardiovascular system in young
people with arterial hypertension and high normal blood pressure// Abstract of a
PhD thesis for a PhD in medicine. – 2006. – 22 p.
Kotovskaya Yu.V., Kobalava Zh.D. Is primary drug prevention of arterial
hypertension possible? Results of the TROPHY study // Cardiology. 2006. - No. 10.
- P. 51 - 57.
Lim SS, Vos T, Flaxman AD, Danaei G: A comparative risk assessment of the
burden of disease and injury attributable to 67 risk factors and risk factor clusters in
regions, 1990-2010: a systematic analysis for the Global Burden of Disease
Study // Lancet. – 2012. - No. 380 (9859). – R. 2224-2260.
Namakanov B.A. Familial arterial hypertension: clinical features and diagnostic
criteria // Doctor. - 2003. - No.: 7. - P. 41-43.
Robert J. Garrison. Incidence and precursors of hypertension in young adults: The
Framingham offspring study//Preventive Medicine.- 1987.-V.16.- Issue 2.- 235-251
Shinbolatova A.A., Nurbaqyt A.N., Zhunisova M.A. Efficiency of detection of
arterial hypertension at early stages// Medicine. 2014.- No. 12.- P.23-26 20 A.
Supiyev , A. Kossumov , L. Utepova , T. Nurgozhin, Z. Zhumadilov , M. Bobak .
Prevalence, awareness, treatment and control of arterial hypertension in Astana,
Kazakhstan. A cross-sectional study // Public heals. -2015.- No. 129.- P. 948- 953
Weber V.R., Kazymov M.S., Kopina M.N., Rubanova M.P., Shmatko D.P.,
Zakharova Yu.V., Mishkina M.Yu. Features of the prevalence of excess body
weight , arterial hypertension, hyperglycemia and their combinations in individuals
of different sexes and ages // Therapeutic arch. - 2008. - 80, No. 9. - P. 76-78. -
Rus.; res. English - ISSN 0040-3660. - RU
World Health Organization-WHO. Non communicable diseases country profiles:
- Geneva: World Health Organization, 2014. – 201 p
